Pursuant to the Capital Market Law and the Rules of the Zagreb Stock
Exchange, we hereby inform you that Podravka d.d. Supervisory Board Session was
held on 20th December 2012. At this session Podravka d.d.
Supervisory Board consented to Podravka Group Business Plan for 2013, along
with the Podravka Group Strategy for the upcoming five-year period. Emphasis is
on increased operating efficiency of business, profitable growth, with
additional strengthening of positions on domestic and key foreign markets.
Considering that
Podravka stocks are listed in the Official market of the Zagreb Stock Exchange,
with the purpose of more favourable financing, Podravka will try to ensure
financing in the capital market.
At the same session, as suggested by the Management Board president, it
is decided that Podravka Management Board be added with another member, with
the purpose of strengthening of Podravka Group pharmaceutical part of business
and for better synergy between the food processing and pharmaceutical segment
of business. Podravka
d.d. Supervisory Board appointed Hrvoje Kolarić as the new member of Podravka
d.d. Management Board, as of 20th December 2012.
Mr. Hrvoje Kolarić will
continue to perform his duties as President of the Management Board of Belupo
d.d.
Hrvoje
Kolarić graduated in 1998 from the Faculty of Pharmacy and Biochemistry in
Zagreb, and in 2011 he received his MBA
from IEDC Bled.
In his business career he was a director of BMS Pharmaceuticals, product
niche and business development, then a director of PharmaSwiss d.o.o. Croatia,
a manager at Bristol – Mayers Squibb branch office for Croatia and Bosnia&
Herzegovina, then a manager for allergy and respiratory products at Schering
Plough branch office in Croatia.
He was appointed Belupo d.d. Management Board member in May 2005, and in
May 2012 he was appointed Belupo d.d. Management Board president.